List of Figures |
Figure 1‑1: Infusion Therapy Device Market Share Ranking by Segment, U.S., 2022 | 5 |
Figure 1‑2: Companies Researched in This Report | 6 |
Figure 1‑3: Factors Impacting the Infusion Therapy Device Market by Segment, U.S. | 7 |
Figure 1‑4: Recent Events in the Infusion Therapy Device Market, U.S., 2019 – 2023 | 8 |
Figure 1‑5: Infusion Therapy Device Markets Covered (1 of 5) | 9 |
Figure 1‑6: Infusion Therapy Device Markets Covered (2 of 5) | 10 |
Figure 1‑7: Infusion Therapy Device Markets Covered (3 of 5) | 11 |
Figure 1‑8: Infusion Therapy Device Markets Covered (4 of 5) | 12 |
Figure 1‑9: Infusion Therapy Device Markets Covered (5 of 5) | 13 |
Figure 1‑10: Key Report Updates | 14 |
Figure 1‑11: Version History | 15 |
Figure 2‑1: Infusion Therapy Device Market by Segment, Worst Case Scenario, U.S., 2019 – 2029 (US$M) | 32 |
Figure 2‑2: Infusion Therapy Device Market by Segment, Base Case Scenario, U.S., 2019 – 2029 (US$M) | 33 |
Figure 2‑3: Infusion Therapy Device Market by Segment, Best Case Scenario, U.S., 2019 – 2029 (US$M) | 34 |
Figure 4‑1: Large-Volume Infusion Pumps by Company | 51 |
Figure 4‑2: Intravenous Sets by Company (1 of 2) | 53 |
Figure 4‑3: Intravenous Sets by Company (2 of 2) | 54 |
Figure 4‑4: Needleless Connectors by Company | 57 |
Figure 4‑5: Stopcocks by Company | 59 |
Figure 4‑6: Intravenous Filters by Company | 60 |
Figure 4‑7: Blood Transfusion Sets by Company | 61 |
Figure 4‑8: Class 1 Device Recall Baxter Spectrum IQ | 62 |
Figure 4‑9: Class 1 Device Recall Baxter SIGMA Spectrum | 62 |
Figure 4‑10: Class 1 Device Recall Spectrum IQ Infusion System with Dose IQ Safety Software | 62 |
Figure 4‑11: Class 2 Device Recall Spectrum IQInfusion Pump | 63 |
Figure 4‑12: Class 2 Device Recall SIGMA Spectrum Infusion Pump | 63 |
Figure 4‑13: Class 1 Device Recall Spectrum IQ | 63 |
Figure 4‑14: Class 1 Device Recall Baxter SIGMA Spectrum Infusion Pump | 63 |
Figure 4‑15: Class 2 Device Recall Baxter SIGMA Spectrum Infusion Pump | 64 |
Figure 4‑16: Class 2 Device Recall B. Braun | 64 |
Figure 4‑17: Class 2 Device Recall Infusomat Space Volumetric Pump Administration Set | 64 |
Figure 4‑18: Class 1 Device Recall Infusomat Space Volumetric Infusion Pump Administration Set | 65 |
Figure 4‑19: Class 2 Device Recall Alaris PC Unit | 65 |
Figure 4‑20: Class 1 Device Recall Alaris Infusion Pump Module | 65 |
Figure 4‑21: Class 1 Device Recall Alaris Pump Module | 65 |
Figure 4‑22: Class 1 Device Recall Alaris Pump Module | 66 |
Figure 4‑23: Class 1 Device Recall Alaris Pump | 66 |
Figure 4‑24: Class 1 Device Recall BD Alaris Pump Module | 66 |
Figure 4‑25: Class 1 Device Recall BD Alaris System PC Unit | 67 |
Figure 4‑26: Class 1 Device Recall Alaris System PC Unit | 67 |
Figure 4‑27: Class 1 Device Recall Alaris Infusion Pump System | 67 |
Figure 4‑28: Class 2 Device Recall BD Alaris" System | 67 |
Figure 4‑29: Class 2 Device Recall Alaris Pump Module | 68 |
Figure 4‑30: Class 2 Device Recall Alaris Syringe Module | 68 |
Figure 4‑31: Class 2 Device Recall Alaris PCA Module | 68 |
Figure 4‑32: Class 1 Device Recall CareFusion Alaris Pump | 69 |
Figure 4‑33: Class 2 Device Recall Plum 360 Infusion System with MedNet/Smart Card Plug n Play Module | 69 |
Figure 4‑34: Class 1 Device Recall Medfusion Model 4000 Pump | 69 |
Figure 4‑35: Class 2 Device Recall Medfusion Model 4000 Syringe Infusion Pump | 70 |
Figure 4‑36: Class 2 Device Recall Clearlink System ContinuFlo Administration Sets | 71 |
Figure 4‑37: Class 2 Device Recall Infusomat Space Volumetric Pump Administration Set | 71 |
Figure 4‑38: Class 1 Device Recall Infusomat Space Volumetric Infusion Pump Administration Set | 71 |
Figure 4‑39: Class 2 Device Recall BD Extension Set SMALLBORE Tubing with 2 SmartSite VALVES | 72 |
Figure 4‑40: Class 2 Device Recall BD SmartSite 'Y' Extension Set 2 NeedleFree Valves | 72 |
Figure 4‑41: Class 2 Device Recall BD Extension Set SMALLBORE Tubing SmartSite VALVE | 72 |
Figure 4‑42: Class 2 Device Recall BD Gravity IV Set 3port Closed Manifold Back Check Valve 3 NeedleFree Ysites | 73 |
Figure 4‑43: Class 2 Device Recall MaxPlus Bi Fuse Extension Set with 2 Clear Needleless Connectors | 73 |
Figure 4‑44: Class 2 Device Recall BD Alaris PCEA Administration Set | 73 |
Figure 4‑45: Class 2 Device Recall MaxZero | 74 |
Figure 4‑46: Class 1 Device Recall SmartSite Syringe Administration Set | 74 |
Figure 4‑47: Class 2 Device Recall Plum 360 Infusion System | 74 |
Figure 4‑48: Class 2 Device Recall Sapphire Primary 1.2 Micron Filter Set Microbore Plum Microbore Infusion Sets with Inline Filter | 74 |
Figure 4‑49: Class 2 Device Recall ONELINK Needlefree IV Connector | 75 |
Figure 4‑50: Class 2 Device Recall MicroClave Clear Neutral Connector | 75 |
Figure 4‑51: Class 2 Device Recall BD SmartSite | 75 |
Figure 4‑52: Class 2 Device Recall ONELINK Needlefree IV Connector | 76 |
Figure 4‑53: Class 2 Device Recall Argon Medical Devices Stopcocks | 77 |
Figure 4‑54: Class 2 Device Recall BD Connecta Stopcocks | 77 |
Figure 4‑55: Class 2 Device Recall IV Administration Set | 78 |
Figure 4‑56: Class 2 Device Recall NAMIC Stopcocks | 78 |
Figure 4‑57: Class 2 Device Recall Infusion Stopcock | 78 |
Figure 4‑58: Class 2 Device Recall Medex stopcocks and manifolds | 78 |
Figure 4‑59: Class 1 Device Recall Fresh Whole Blood Transfusion Set | 79 |
Figure 4‑60: Class 1 Device Recall Low Titer Type O FWB Transfusion Set | 79 |
Figure 4‑61: Hepatic Artery Infusion Pump Chemotherapy with Floxuridine and Dexamethasone in Combination with Systemic Chemotherapy for Patients with Colorectal Cancer Metastatic to the Liver | 81 |
Figure 4‑62: Patient Outcomes After Hepatic Artery Infusion Pump Placement | 81 |
Figure 4‑63: Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin (EVOLVE) | 82 |
Figure 4‑64: ElastoMeric Infusion Pumps for Hospital AntibioTICs (EMPHATIC) | 82 |
Figure 4‑65: Prometra Post-Approval Study | 82 |
Figure 4‑66: Hepatic Arterial Infusion Pump Chemotherapy Combined with Systemic Chemotherapy (PUMP-IT) | 83 |
Figure 4‑67: Treatment of (IDA) by (FPC) Delivered via Infusion Pump in Patients Receiving Home Infusion Therapy | 83 |
Figure 4‑68: An Observational Study to Evaluate BD PureHub™ Disinfecting Cap Use on Needle-Free Connectors | 84 |
Figure 4‑69: Blood Transfusion in Patients with Lung Cancer | 85 |
Figure 4‑70: Effect of Indication Based Blood Product Transfusion in Patients Undergoing Major Oncological Surgery | 85 |
Figure 5‑1: Infusion Therapy Device Market by Segment, U.S., 2019 – 2029 (US$M) | 90 |
Figure 5‑2: Leading Competitors, Infusion Therapy Device Market, U.S., 2022 | 101 |
Figure 5‑3: SWOT Analysis, Avanos Medical | 117 |
Figure 5‑4: SWOT Analysis, B. Braun | 118 |
Figure 5‑5: SWOT Analysis, Baxter | 119 |
Figure 5‑6: SWOT Analysis, Becton Dickinson | 120 |
Figure 5‑7: SWOT Analysis, Belmont Medical | 121 |
Figure 5‑8: SWOT Analysis, CODAN | 122 |
Figure 5‑9: SWOT Analysis, Fresenius | 123 |
Figure 5‑10: SWOT Analysis, GVS Group | 124 |
Figure 5‑11: SWOT Analysis, ICU Medical | 125 |
Figure 5‑12: SWOT Analysis, Vygon | 126 |
Figure 6‑1: Infusion Pump Market by Segment, U.S., 2019 – 2029 (US$M) | 130 |
Figure 6‑2: Total Large-Volume Infusion Pump Market, U.S., 2019 – 2029 | 133 |
Figure 6‑3: Large-Volume Infusion Pump Market by Care Setting, U.S., 2019 – 2029 (US$M) | 135 |
Figure 6‑4: Hospital Large-Volume Infusion Pump Market, U.S., 2019 – 2029 | 137 |
Figure 6‑5: Specialty Clinics Care Large-Volume Infusion Pump Market, U.S., 2019 – 2029 | 138 |
Figure 6‑6: Ambulatory Surgical Center Large-Volume Infusion Pump Market, U.S., 2019 – 2029 | 139 |
Figure 6‑7: Home Care Setting Large-Volume Infusion Pump Market, U.S., 2019 – 2029 | 140 |
Figure 6‑8: Large-Volume Infusion Pump Market by Modularity, U.S., 2019 – 2029 (US$M) | 142 |
Figure 6‑9: Modular Large-Volume Infusion Pump Market, U.S., 2019 – 2029 | 143 |
Figure 6‑10: Non-Modular Large-Volume Infusion Pump Market, U.S., 2019 – 2029 | 144 |
Figure 6‑11: Large-Volume Infusion Pump Market by MRI Compatibility, U.S., 2019 – 2029 (US$M) | 146 |
Figure 6‑12: MRI-Compatible Large-Volume Infusion Pump Market, U.S., 2019 – 2029 | 147 |
Figure 6‑13: Non-MRI-Compatible Large-Volume Infusion Pump Market, U.S., 2019 – 2029 | 148 |
Figure 6‑14: Total Syringe Infusion Pump Market, U.S., 2019 – 2029 | 150 |
Figure 6‑15: Syringe Infusion Pump Market by Care Setting, U.S., 2019 – 2029 (US$M) | 152 |
Figure 6‑16: Hospital Syringe Infusion Pump Market, U.S., 2019 – 2029 | 153 |
Figure 6‑17: Specialty Clinics Care Syringe Infusion Pump Market, U.S., 2019 – 2029 | 154 |
Figure 6‑18: Ambulatory Surgical Center Syringe Infusion Pump Market, U.S., 2019 – 2029 | 155 |
Figure 6‑19: Home Care Setting Syringe Infusion Pump Market, U.S., 2019 – 2029 | 156 |
Figure 6‑20: Syringe Infusion Pump Market by Modularity, U.S., 2019 – 2029 (US$M) | 158 |
Figure 6‑21: Modular Syringe Infusion Pump Market, U.S., 2019 – 2029 | 159 |
Figure 6‑22: Non-Modular Syringe Infusion Pump Market, U.S., 2019 – 2029 | 160 |
Figure 6‑23: Total Patient-Controlled Analgesia Infusion Pump Market, U.S., 2019 – 2029 | 162 |
Figure 6‑24: Patient-Controlled Analgesia Infusion Pump Market by Care Setting, U.S., 2019 – 2029 (US$M) | 164 |
Figure 6‑25: Hospital Patient-Controlled Analgesia Infusion Pump Market, U.S., 2019 – 2029 | 165 |
Figure 6‑26: Specialty Clinics Patient-Controlled Analgesia Infusion Pump Market, U.S., 2019 – 2029 | 166 |
Figure 6‑27: Ambulatory Surgical Center Patient-Controlled Analgesia Infusion Pump Market, U.S., 2019 – 2029 | 167 |
Figure 6‑28: Home Care Setting Patient-Controlled Analgesia Infusion Pump Market, U.S., 2019 – 2029 | 168 |
Figure 6‑29: Total Electronic Ambulatory Infusion Pump Market, U.S., 2019 – 2029 | 169 |
Figure 6‑30: Electronic Ambulatory Infusion Pump Market by Care Setting, U.S., 2019 – 2029 (US$M) | 171 |
Figure 6‑31: Hospital Electronic Ambulatory Infusion Pump Market, U.S., 2019 – 2029 | 172 |
Figure 6‑32: Specialty Clinics Electronic Ambulatory Infusion Pump Market, U.S., 2019 – 2029 | 173 |
Figure 6‑33: Ambulatory Surgical Center Electronic Ambulatory Infusion Pump Market, U.S., 2019 – 2029 | 174 |
Figure 6‑34: Home Care Setting Electronic Ambulatory Infusion Pump Market, U.S., 2019 – 2029 | 175 |
Figure 6‑35: Total Disposable Ambulatory Infusion Pump Market, U.S., 2019 – 2029 | 176 |
Figure 6‑36: Disposable Ambulatory Infusion Pump Market by Type, U.S., 2019 – 2029 (US$M) | 177 |
Figure 6‑37: Disposable Ambulatory Non-Pain Infusion Pump Market, U.S., 2019 – 2029 | 178 |
Figure 6‑38: Disposable Ambulatory Pain Infusion Pump Market by Type, U.S., 2019 – 2029 (US$M) | 179 |
Figure 6‑39: Total Disposable Ambulatory Pain Infusion Pump Market, U.S., 2019 – 2029 | 180 |
Figure 6‑40: Surgical Post-Operative Disposable Ambulatory Pain Infusion Pump Market, U.S., 2019 – 2029 | 181 |
Figure 6‑41: Peripheral Nerve Block Disposable Ambulatory Pain Infusion Pump Market, U.S., 2019 – 2029 | 182 |
Figure 6‑42: Disposable Ambulatory Infusion Pump Market by Care Setting, U.S., 2019 – 2029 (US$M) | 184 |
Figure 6‑43: Hospital Disposable Ambulatory Infusion Pump Market, U.S., 2019 – 2029 | 185 |
Figure 6‑44: Specialty Clinics Disposable Ambulatory Infusion Pump Market, U.S., 2019 – 2029 | 186 |
Figure 6‑45: Ambulatory Surgical Center Disposable Ambulatory Infusion Pump Market, U.S., 2019 – 2029 | 187 |
Figure 6‑46: Home Care Setting Disposable Ambulatory Infusion Pump Market, U.S., 2019 – 2029 | 188 |
Figure 6‑47: Leading Competitors, Infusion Pump Market, U.S., 2022 | 199 |
Figure 7‑1: Intravenous Set Market by Device Type, U.S., 2019 – 2029 (US$M) | 203 |
Figure 7‑2: Intravenous Set Market by Material, U.S., 2019 – 2029 (US$M) | 205 |
Figure 7‑3: Total Pump Set Market, U.S., 2019 – 2029 | 208 |
Figure 7‑4: Pump Set Market by Device Type, U.S., 2019 – 2029 (US$M) | 209 |
Figure 7‑5: Dedicated Pump Set Market by Application, U.S., 2019 – 2029 (US$M) | 211 |
Figure 7‑6: Total Dedicated Pump Set Market, U.S., 2019 – 2029 | 211 |
Figure 7‑7: General Ward Dedicated Pump Set Market, U.S., 2019 – 2029 | 212 |
Figure 7‑8: Burette Dedicated Pump Set Market, U.S., 2019 – 2029 | 213 |
Figure 7‑9: Oncology Dedicated Pump Set Market, U.S., 2019 – 2029 | 214 |
Figure 7‑10: Total Parenteral Nutrition Dedicated Pump Set Market, U.S., 2019 – 2029 | 215 |
Figure 7‑11: Non-Dedicated Pump Set Market, U.S., 2019 – 2029 | 216 |
Figure 7‑12: Pump Set Market by Light Protection, U.S., 2019 – 2029 (US$M) | 217 |
Figure 7‑13: Light-Protected Pump Set Market, U.S., 2019 – 2029 | 218 |
Figure 7‑14: Non-Light-Protected Pump Set Market, U.S., 2019 – 2029 | 219 |
Figure 7‑15: Pump Set Market by Patient Age, U.S., 2019 – 2029 (US$M) | 220 |
Figure 7‑16: Pediatric and Neonatal Pump Set Market, U.S., 2019 – 2029 | 221 |
Figure 7‑17: Adult Pump Set Market, U.S., 2019 – 2029 | 222 |
Figure 7‑18: Pump Set Market by Care Setting, U.S., 2019 – 2029 (US$M) | 223 |
Figure 7‑19: Hospital Pump Set Market, U.S., 2019 – 2029 | 224 |
Figure 7‑20: Specialty Clinics Pump Set Market, U.S., 2019 – 2029 | 225 |
Figure 7‑21: Ambulatory Surgical Center Pump Set Market, U.S., 2019 – 2029 | 226 |
Figure 7‑22: Home Care Setting Pump Set Market, U.S., 2019 – 2029 | 227 |
Figure 7‑23: Total Gravity Set Market, U.S., 2019 – 2029 | 228 |
Figure 7‑24: Gravity Set Market by Application, U.S., 2019 – 2029 (US$M) | 229 |
Figure 7‑25: General Ward Gravity Set Market, U.S., 2019 – 2029 | 230 |
Figure 7‑26: General Ward Set Market by Y-Site, U.S., 2019 – 2029 (US$M) | 231 |
Figure 7‑27: General Ward Gravity Set Market by Needle-Free Access Port, U.S., 2019 – 2029 (US$M) | 232 |
Figure 7‑28: General Ward Gravity Set with Y-Site Market, U.S., 2019 – 2029 | 233 |
Figure 7‑29: General Ward Gravity Set with Y-Site with Needle-Free Access Port Market, U.S., 2019 – 2029 | 234 |
Figure 7‑30: General Ward Gravity Set with Y-Site without Needle-Free Access Port Market, U.S., 2019 – 2029 | 235 |
Figure 7‑31: General Ward Gravity Set without Y-Site Market, U.S., 2019 – 2029 | 236 |
Figure 7‑32: General Ward Gravity Set Market by Filter, U.S., 2019 – 2029 (US$M) | 237 |
Figure 7‑33: General Ward Gravity Set with Filter Market, U.S., 2019 – 2029 | 238 |
Figure 7‑34: General Ward Gravity Set without Filter Market, U.S., 2019 – 2029 | 239 |
Figure 7‑35: General Ward Gravity Set Market by Stopcock, U.S., 2019 – 2029 (US$M) | 240 |
Figure 7‑36: General Ward Gravity Set with Stopcock Market, U.S., 2019 – 2029 | 241 |
Figure 7‑37: General Ward Gravity Set without Stopcock Market, U.S., 2019 – 2029 | 242 |
Figure 7‑38: General Ward Gravity Set Market by Flow Control, U.S., 2019 – 2029 (US$M) | 243 |
Figure 7‑39: General Ward Gravity Set with Flow Control Market, U.S., 2019 – 2029 | 244 |
Figure 7‑40: General Ward Gravity Set without Flow Control Market, U.S., 2019 – 2029 | 245 |
Figure 7‑41: Burette Gravity Set Market, U.S., 2019 – 2029 | 246 |
Figure 7‑42: Oncology Gravity Set Market, U.S., 2019 – 2029 | 247 |
Figure 7‑43: Gravity Set Market by Care Setting, U.S., 2019 – 2029 (US$M) | 248 |
Figure 7‑44: Hospital Gravity Set Market, U.S., 2019 – 2029 | 249 |
Figure 7‑45: Specialty Clinics Gravity Set Market, U.S., 2019 – 2029 | 250 |
Figure 7‑46: Ambulatory Surgical Center Gravity Set Market, U.S., 2019 – 2029 | 251 |
Figure 7‑47: Home Care Setting Gravity Set Market, U.S., 2019 – 2029 | 252 |
Figure 7‑48: Total Secondary Set Market, U.S., 2019 – 2029 | 253 |
Figure 7‑49: Secondary Set Market by Care Setting, U.S., 2019 – 2029 | 254 |
Figure 7‑50: Hospital Secondary Set Market, U.S., 2019 – 2029 | 255 |
Figure 7‑51: Specialty Clinics Secondary Set Market, U.S., 2019 – 2029 | 256 |
Figure 7‑52: Ambulatory Surgical Center Secondary Set Market, U.S., 2019 – 2029 | 257 |
Figure 7‑53: Home Care Setting Secondary Set Market, U.S., 2019 – 2029 | 258 |
Figure 7‑54: Total Extension Set Market, U.S., 2019 – 2029 | 260 |
Figure 7‑55: Extension Set Market by Configuration, U.S., 2019 – 2029 (US$M) | 261 |
Figure 7‑56: Standard Extension Set Market, U.S., 2019 – 2029 | 262 |
Figure 7‑57: Multi-Way Extension Set Market, U.S., 2019 – 2029 | 263 |
Figure 7‑58: Extension Set Market by IV Filter, U.S., 2019 – 2029 (US$M) | 265 |
Figure 7‑59: Extension Set with Built-in IV Filter Market, U.S., 2019 – 2029 | 266 |
Figure 7‑60: Extension Set without Built-in IV Filter Market, U.S., 2019 – 2029 | 267 |
Figure 7‑61: Extension Set Market by Stopcock, U.S., 2019 – 2029 (US$M) | 268 |
Figure 7‑62: Extension Set with Built-in Stopcock Market, U.S., 2019 – 2029 | 269 |
Figure 7‑63: Extension Set without Built-in Stopcock Market, U.S., 2019 – 2029 | 270 |
Figure 7‑64: Extension Set Market by Flow Control, U.S., 2019 – 2029 (US$M) | 272 |
Figure 7‑65: Extension Set with Flow Control Market, U.S., 2019 – 2029 | 273 |
Figure 7‑66: Extension Set without Flow Control Market, U.S., 2019 – 2029 | 274 |
Figure 7‑67: Extension Set Market by Care Setting, U.S., 2019 – 2029 (US$M) | 275 |
Figure 7‑68: Hospital Extension Set Market, U.S., 2019 – 2029 | 276 |
Figure 7‑69: Specialty Clinics Extension Set Market, U.S., 2019 – 2029 | 277 |
Figure 7‑70: Ambulatory Surgical Center Extension Set Market, U.S., 2019 – 2029 | 278 |
Figure 7‑71: Home Care Setting Extension Set Market, U.S., 2019 – 2029 | 279 |
Figure 7‑72: DEHP IV Set Market, U.S., 2019 – 2029 | 280 |
Figure 7‑73: Non-DEHP IV Set Market, U.S., 2019 – 2029 | 281 |
Figure 7‑74: Leading Competitors, Intravenous Set Market, U.S., 2022 | 287 |
Figure 8‑1: Needleless Connector Market by Valve Type, U.S., 2019 – 2029 (US$M) | 291 |
Figure 8‑2: Needleless Connector Market by Device Type, U.S., 2019 – 2029 (US$M) | 293 |
Figure 8‑3: Needleless Connector Market by Antimicrobial Coating, U.S., 2019 – 2029 (US$M) | 295 |
Figure 8‑4: Needleless Connector Market by Care Setting, U.S., 2019 – 2029 (US$M) | 297 |
Figure 8‑5: Total Needleless Connector Market, U.S., 2019 – 2029 | 299 |
Figure 8‑6: Split Septum & Blunt Cannula Needleless Connector Market, U.S., 2019 – 2029 | 301 |
Figure 8‑7: Mechanical Valve Needleless Connector Market by Device Type, U.S., 2019 – 2029 (US$M) | 303 |
Figure 8‑8: Total Mechanical Valve Needleless Connector Market, U.S., 2019 – 2029 | 304 |
Figure 8‑9: Negative Displacement Mechanical Valve Needleless Connector Market, U.S., 2019 – 2029 | 305 |
Figure 8‑10: Positive Displacement Mechanical Valve Needleless Connector Market, U.S., 2019 – 2029 | 306 |
Figure 8‑11: Neutral Displacement Mechanical Valve Needleless Connector Market, U.S., 2019 – 2029 | 307 |
Figure 8‑12: Anti-Reflux Neutral Displacement Mechanical Valve Needleless Connector Market, U.S., 2019 – 2029 | 308 |
Figure 8‑13: Standalone Needleless Connector Market, U.S., 2019 – 2029 | 310 |
Figure 8‑14: Integrated Needleless Connector Market, U.S., 2019 – 2029 | 311 |
Figure 8‑15: Needleless Connector Market by Antimicrobial Coating, U.S., 2019 – 2029 (US$M) | 313 |
Figure 8‑16: Antimicrobial Needleless Connector Market, U.S., 2019 – 2029 | 314 |
Figure 8‑17: Conventional Needleless Connector Market, U.S., 2019 – 2029 | 315 |
Figure 8‑18: Needleless Connector Market by Care Setting, U.S., 2019 – 2029 (US$M) | 316 |
Figure 8‑19: Hospital Needleless Connector Market, U.S., 2019 – 2029 | 317 |
Figure 8‑20: Specialty Clinics Needleless Connector Market, U.S., 2019 – 2029 | 318 |
Figure 8‑21: Ambulatory Surgical Center Needleless Connector Market, U.S., 2019 – 2029 | 320 |
Figure 8‑22: Home Care Setting Needleless Connector Market, U.S., 2019 – 2029 | 321 |
Figure 8‑23: Leading Competitors, Needleless Connector Market, U.S., 2022 | 326 |
Figure 9‑1: Stopcock Market by Flow Type, U.S., 2019 – 2029 (US$M) | 330 |
Figure 9‑2: Stopcock Market by Care Setting, U.S., 2019 – 2029 (US$M) | 332 |
Figure 9‑3: Total Stopcock Market, U.S., 2019 – 2029 | 334 |
Figure 9‑4: One-Way Stopcock Market, U.S., 2019 – 2029 | 336 |
Figure 9‑5: Two-Way Stopcock Market, U.S., 2019 – 2029 | 337 |
Figure 9‑6: Three-Way Stopcock Market, U.S., 2019 – 2029 | 338 |
Figure 9‑7: Four-Way Stopcock Market, U.S., 2019 – 2029 | 339 |
Figure 9‑8: Stopcock Market by Care Setting, U.S., 2019 – 2029 (US$M) | 341 |
Figure 9‑9: Hospital Stopcock Market, U.S., 2019 – 2029 | 342 |
Figure 9‑10: Specialty Clinics Stopcock Market, U.S., 2019 – 2029 | 343 |
Figure 9‑11: Ambulatory Surgical Center Stopcock Market, U.S., 2019 – 2029 | 344 |
Figure 9‑12: Home Care Setting Stopcock Market, U.S., 2019 – 2029 | 345 |
Figure 9‑13: Leading Competitors, Stopcock Market, U.S., 2022 | 350 |
Figure 10‑1: Intravenous Filter Market by Care Setting, U.S., 2019 – 2029 (US$M) | 354 |
Figure 10‑2: Total Intravenous Filter Market, U.S., 2019 – 2029 | 357 |
Figure 10‑3: Hospital Intravenous Filter Market, U.S., 2019 – 2029 | 360 |
Figure 10‑4: Specialty Clinics Intravenous Filter Market, U.S., 2019 – 2029 | 362 |
Figure 10‑5: Ambulatory Surgical Center Intravenous Filter Market, U.S., 2019 – 2029 | 364 |
Figure 10‑6: Home Care Setting Intravenous Filter Market, U.S., 2019 – 2029 | 366 |
Figure 10‑7: Leading Competitors, Intravenous Filter Market, U.S., 2022 | 370 |
Figure 11‑1: Blood Transfusion Device Market by Chamber Type, U.S., 2019 – 2029 (US$M) | 374 |
Figure 11‑2: Blood Transfusion Device Market by Care Setting, U.S., 2019 – 2029 (US$M) | 376 |
Figure 11‑3: Total Blood Transfusion Device Market, U.S., 2019 – 2029 | 378 |
Figure 11‑4: Single-Chamber Blood Transfusion Device Market, U.S., 2019 – 2029 | 380 |
Figure 11‑5: Dual-Chamber Blood Transfusion Device Market, U.S., 2019 – 2029 | 381 |
Figure 11‑6: Hospital Blood Transfusion Device Market, U.S., 2019 – 2029 | 384 |
Figure 11‑7: Specialty Clinics Blood Transfusion Device Market, U.S., 2019 – 2029 | 386 |
Figure 11‑8 Other Blood Transfusion Device Market, U.S., 2019 – 2029 | 388 |
Figure 11‑9: Leading Competitors, Blood Transfusion Device Market, U.S., 2022 | 392 |